NEURAXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.03 USD | +4.12% |
|
-1.94% | +13.48% |
| May. 22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
| May. 22 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Valuation
| Fiscal Period: December | 2023 | 2024 |
|---|---|---|
| Capitalization 1 | 14.12 | 19.98 |
| Enterprise Value (EV) 1 | 14.12 | 19.98 |
| P/E ratio | - | - |
| Yield | - | - |
| Capitalization / Revenue | 5.74 x | 1.71 x |
| EV / Revenue | 5.74 x | 1.71 x |
| EV / EBITDA | - | - |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Price to Book | - | - |
| Nbr of stocks (in thousands) | 5,290 | 6,595 |
| Reference price 2 | 2.670 | 3.030 |
| Announcement Date | 4/16/24 | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net sales 1 | - | 2.46 | 11.65 |
| EBITDA | - | - | - |
| EBIT 1 | - | -6.664 | -0.6272 |
| Operating Margin | - | -270.91% | -5.38% |
| Earnings before Tax (EBT) | - | - | - |
| Net income | -4.78 | - | - |
| Net margin | - | - | - |
| EPS | -2.770 | - | - |
| Free Cash Flow | - | - | - |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 6/1/23 | 4/16/24 | - |
1USD in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|
| Net sales 1 | 0.5315 | 0.6466 | 2.669 | 3.135 | 3.619 |
| EBITDA | - | - | - | - | - |
| EBIT 1 | -1.623 | -1.832 | -0.3006 | -0.0055 | 0.2737 |
| Operating Margin | -305.42% | -283.33% | -11.26% | -0.18% | 7.56% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| EPS | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 4/16/24 | 5/20/24 | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Debt | - | - | - |
| Net Cash position | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 6/1/23 | 4/16/24 | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.03
USD
Average target price
7.5
USD
Spread / Average Target
+147.52%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +13.48% | 19.98M | |
| +75.33% | 12.54B | |
| -24.19% | 7.39B | |
| +6.43% | 6.62B | |
| +13.59% | 5.43B | |
| +34.82% | 4.81B | |
| -15.23% | 4.8B | |
| -25.57% | 3.72B | |
| -26.93% | 2.76B | |
| +49.43% | 2.4B |
- Stock Market
- Equities
- NRXS Stock
- Financials NeurAxis, Inc.
